COVID-19 Latest Fred Hutch research on COVID-19In the past month, our scientists have published findings on how SARS-CoV-2 mutates and what that may mean for vaccine efficacy, how machine learning may help dampen the cytokine storm from COVID-19 and comparing immune responses from infection versus vaccination.Media contact: Claire Hudson, firstname.lastname@example.org
Health disparities Dr. Julie Overbaugh elected to National Academy of SciencesVirologist Dr. Julie Overbaugh, who studies factors that shape HIV transmission, was elected to the National Academy of Sciences. Overbaugh is one of 120 new members, including a record number of women, elected by their peers in recognition of their distinguished and continuing achievements in research.Media contact: Molly McElroy, email@example.com
Hutch researchers discover neutralizing antibodies to parainfluenzaA team of researchers led by Dr. Justin Taylor describes how they isolated five different antibodies that, in lab dish studies, potently protect against human parainfluenza virus type III, or HPIV3. Their work was published on April 20 in the open access journal mAbs.Media contact: Claire Hudson, firstname.lastname@example.org Basic Sciences
Vaccine and infectious diseases Event: Pathways to Equity SymposiumFred Hutch’s Office of Community Outreach and Engagement will be hosting their annual Pathways to Equity Symposium on Friday, May 2, 8:30am-12:30pm PT. Speakers will discuss racial/social justice, health equity and community engagement. Registration is free. RSVP here.
Cancer research Careful pruning guides neuron functionDr. Aakanksha Singhvi used tiny worms with well-mapped nervous systems in her latest work that was published in the journal eLife. She and a graduate student, Stephan Raiders, collaborated to learn how the role of accessory brain cells called glial cells support neuron function.Media contact: Molly McElroy, email@example.com
Event: B+T = ImmunotherapyDrs. Jim Boonyaratanakornkit, Stan Riddell and Shivani Srivastava joined Dr. Bruce Clurman, Fred Hutch executive vice president and deputy director, to discuss their work studying immune cells to develop treatments for cancers and infectious diseases. Dr. Rachel Bender Ignacio also gave us an update on COVID-19 treatments happening at the Hutch’s COVID-19 Clinical Research Center. The event is part of the Hutch public science series, Science Says. Our next Science Says, on the importance of diversity and equity in science, will be June 15. Register here.Media contact: Molly McElroy, firstname.lastname@example.org Other notable news Seeking to expand targeted therapy for lung cancerLung cancer researcher Dr. Alice Berger received a National Institutes of Health MERIT Award that will support her efforts to extend advances to more patients with this cancer. Berger’s MERIT Award will fund seven years of investigations into a gene that’s mutated in a subset of non-small cell lung cancer and other tumors, including some leukemias. Her ultimate goal is to extend the power of targeted therapy to more patients with lung cancer.Media contact: Molly McElroy, email@example.com
News Highlights Health
- The Latest Research on COVID-19, Health Disparities, Parainfluenza Antibodies, and Neural Function
- Check all news and articles from the Health news information updates.